Milliman Healthcare Inflation Guard ETF
Milliman Healthcare Inflation Guard ETF reported 64 holdings worth US$988K as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 26, 2026
Milliman Healthcare Inflation Guard ETF reported 64 holdings worth US$988K as of Jun 30, 2026. Largest: Eli Lilly And Company, Unitedhealth Group Incorporated and Johnson & Johnson. Filed Aug 26, 2026 (Form N-PORT).
- Holdings
- 64
- Value as reported
- US$988K
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 14 | US$16,792 | 1.7% |
| Unitedhealth Group Incorporated | 35 | US$14,547 | 1.5% |
| Johnson & Johnson | 40 | US$10,159 | 1.0% |
| Thermo Fisher Scientific Inc | 20 | US$10,027 | 1.0% |
| Abbott Laboratories | 92 | US$8,348 | 0.85% |
| Intuitive Surgical, Inc. | 19 | US$7,556 | 0.76% |
| Danaher Corporation | 38 | US$7,238 | 0.73% |
| Stryker Corporation | 20 | US$6,297 | 0.64% |
| Merck & Company, Inc. | 47 | US$6,040 | 0.61% |
| Medtronic Plc. | 69 | US$5,398 | 0.55% |
| Cvs Health Corporation | 48 | US$4,966 | 0.50% |
| Abbvie Inc. | 17 | US$4,278 | 0.43% |
| Mckesson Corporation | 5 | US$3,778 | 0.38% |
| Boston Scientific Corporation | 83 | US$3,542 | 0.36% |
| Hca Healthcare, Inc. | 9 | US$3,509 | 0.36% |
| Bristol-myers Squibb Company | 56 | US$3,227 | 0.33% |
| Elevance Health, Inc. | 8 | US$3,094 | 0.31% |
| The Cigna Group | 10 | US$2,757 | 0.28% |
| Edwards Lifesciences Corporation | 30 | US$2,714 | 0.27% |
| Becton, Dickinson And Company | 15 | US$2,270 | 0.23% |
| Cencora, Inc. | 8 | US$2,264 | 0.23% |
| Cardinal Health, Inc. | 9 | US$2,138 | 0.22% |
| Idexx Laboratories, Inc. | 4 | US$2,106 | 0.21% |
| Agilent Technologies, Inc. | 15 | US$1,992 | 0.20% |
| Humana Inc. | 5 | US$1,986 | 0.20% |
| Natera, Inc. | 7 | US$1,900 | 0.19% |
| Medline Inc. | 48 | US$1,893 | 0.19% |
| Waters Corporation | 5 | US$1,875 | 0.19% |
| Iqvia Holdings, Inc. | 9 | US$1,739 | 0.18% |
| Revolution Medicines, Inc. | 9 | US$1,686 | 0.17% |
| Ge Healthcare Technologies Inc. | 26 | US$1,664 | 0.17% |
| United Therapeutics Corporation | 3 | US$1,625 | 0.16% |
| Madrigal Pharmaceuticals, Inc. | 3 | US$1,611 | 0.16% |
| Veeva Systems Inc. | 9 | US$1,597 | 0.16% |
| Resmed Inc. | 8 | US$1,559 | 0.16% |
| Dexcom, Inc. | 22 | US$1,482 | 0.15% |
| Moderna, Inc. | 21 | US$1,471 | 0.15% |
| West Pharmaceutical Services, Inc. | 4 | US$1,436 | 0.15% |
| Illumina, Inc. | 8 | US$1,407 | 0.14% |
| Labcorp Holdings Inc. | 5 | US$1,400 | 0.14% |
| Mettler-toledo International, Inc. | 1 | US$1,278 | 0.13% |
| Quest Diagnostics Incorporated | 6 | US$1,272 | 0.13% |
| Centene Corporation | 19 | US$1,220 | 0.12% |
| Neurocrine Biosciences, Inc. | 7 | US$1,180 | 0.12% |
| Amgen Inc. | 3 | US$1,086 | 0.11% |
| Medpace Holdings, Inc. | 2 | US$1,059 | 0.11% |
| Steris Plc (ireland) | 5 | US$1,053 | 0.11% |
| Guardant Health, Inc. | 7 | US$1,050 | 0.11% |
| Zimmer Biomet Holdings, Inc. | 10 | US$861 | 0.09% |
| The Cooper Companies, Inc. | 11 | US$789 | 0.08% |
| Solventum Corporation | 10 | US$772 | 0.08% |
| Brightspring Health Services, Inc. | 10 | US$697 | 0.07% |
| Align Technology, Inc. | 4 | US$675 | 0.07% |
| Revvity, Inc. | 6 | US$668 | 0.07% |
| Gilead Sciences, Inc. | 5 | US$632 | 0.06% |
| Penumbra, Inc. | 2 | US$632 | 0.06% |
| Insulet Corporation | 4 | US$609 | 0.06% |
| Alnylam Pharmaceuticals, Inc. | 2 | US$602 | 0.06% |
| Tenet Healthcare Corporation | 3 | US$561 | 0.06% |
| Pfizer, Inc. | 23 | US$554 | 0.06% |
| Globus Medical, Inc. | 7 | US$553 | 0.06% |
| Davita Inc. | 2 | US$445 | 0.05% |
| Zoetis Inc. | 2 | US$144 | 0.01% |
| Viatris Inc. | 9 | US$143 | 0.01% |
Source
View original at SEC
Related